Investigation Opened on Behalf of Ardent Health, Inc. (ARDT) Shareholders - Contact Levi & Korsinsky
November 18, 2025 4:48 PM EST | Source: Levi & Korsinsky, LLP
New York, New York--(Newsfile Corp. - November 18, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Ardent Health, Inc. ("Ardent Health, Inc.") (NYSE: ARDT) concerning possible violations of federal securities laws.
Ardent issued a press release on November 12, 2025, announcing its financial results for the third quarter of 2025. In connection with that release, the Company disclosed that it recorded a $43 million reduction in revenue due to a change in accounting estimates regarding the collectability of accounts receivable. Ardent also revealed a $54 million increase to its professional liability reserves related to claims arising in New Mexico.
Following this news, the Company's common stock fell significantly during pre-market trading on November 13, 2025. To obtain additional information, go to:
https://zlk.com/pslra-1/ardent-health-inc-lawsuit-submission-form?prid=178010&wire=5&utm_campaign=44
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212)363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171
https://zlk.com/
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/275089

